The Latest

CVS Limits Opioid Use
CVS Limits Opioid UseThe chain’s PBM will limit opioid prescriptions, along with a host of other opioid safety programs.
FDA Safety Communication for Ocaliva
FDA Safety Communication for OcalivaFDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
CVS Unveils New Vending MachinesThe new machines will feature of variety of OTC meds and other products.
Clinical Challenge: Treating Nasal Congestion with Concomitant Hypertension
Clinical Challenge: Treating Nasal Congestion with Concomitant HypertensionIn Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
Pharmacists Should Have Plans in Place for Disasters
Pharmacists Should Have Plans in Place for DisastersInternational pharmacy group says that pharmacists should create advance plans for major disasters.
Balancing Act: Dealing with Stress in the Pharmacy
Balancing Act: Dealing with Stress in the PharmacyIt's no news that pharmacists are stressed, but how is it affecting job performance—and how do pharmacists cope?
Are You Keeping Your Patients' Digital Info Safe?
Are You Keeping Your Patients' Digital Info Safe?Ransomware and cybersecurity threats expose patients to risks.
The Top 7 Craziest Drugs in the Pipeline
The Top 7 Craziest Drugs in the PipelineNot all drugs are incredible—and sometimes even the incredible ones have weird origins.
Pharmacists Recognized for Cancer Screening EffortsThe FIP awards honored two international pharmacy associations for their recent campaigns.
Rivaroxaban Shown to Cut Risk of Cardiovascular EventsRivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.